Adiponectin and cardiovascular risk prediction: Can the ambiguities be resolved?
- 30 November 2008
- journal article
- editorial
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 18 (9) , 581-584
- https://doi.org/10.1016/j.numecd.2008.07.002
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Adiponectin and cardiovascular disease: state of the art?American Journal of Physiology-Heart and Circulatory Physiology, 2007
- Serum Adiponectin and Coronary Heart Disease Risk in Older Black and White AmericansJournal of Clinical Endocrinology & Metabolism, 2006
- Serum Adiponectin Is a Predictor of Coronary Heart Disease: A Population-Based 10-Year Follow-Up Study in Elderly MenJournal of Clinical Endocrinology & Metabolism, 2006
- Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men: Results From the 18-Year Follow-Up of a Large Cohort From Southern GermanyJournal of the American College of Cardiology, 2006
- Association of Adiponectin with Coronary Heart Disease and Mortality: The Rancho Bernardo StudyAmerican Journal of Epidemiology, 2006
- Adiponectin and Coronary Heart DiseaseCirculation, 2006
- Plasma Adiponectin Levels Are Associated with Insulin Resistance, But Do Not Predict Future Risk of Coronary Heart Disease in WomenJournal of Clinical Endocrinology & Metabolism, 2005
- Adiponectin and Coronary Heart Disease: The Strong Heart StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Adiponectin: action, regulation and association to insulin sensitivityObesity Reviews, 2005
- Plasma Adiponectin Levels and Risk of Myocardial Infarction in MenJAMA, 2004